Heat Biologics: Rises after potential COVID-19 vaccine shows promise in animal testing

Scorpius Holdings

13/08/2020 14:29

** Shares of vaccine developer  HTBX.O  rise 20% to $1.9 in
premarket trade
    ** Co says its experimental COVID-19 vaccine showed positive
results in pre-clinical testing in animals  urn:newsml:reuters.com:*:nACS040gsa
    ** Co says vaccine induced T cells showed immune response 
against SARS-CoV-2 after a single injection 
    ** Up to Wednesday's close, stock has more than tripled so
far this year

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3463;))